COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.


This series of 90-minute webinars features Mayo Clinic experts discussing monoclonal antibodies and other novel therapeutics in COVID-19 treatment. Webinar recordings will be available within 48 hours.  Additional COVID-19 online education and resources are also available.  

Register for Live Webinar

Global COVID-19 pandemic updates from India, Kenya and Ghana

On Tuesday, November 16from 12:00 p.m. to 1:30 p.m. EDT Mayo Clinic and other experts will discuss COVID-19 infection prevalence, virus variants, preventative measures, vaccination status, and therapies used in treating patients in India, Kenya and Ghana. Additionally, impact on the prevalence of HIV, tuberculosis, and malaria will be explored.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Update on SARS-CoV-2 Variants of Concern and Vaccines; Implications for SOT Recipients

On Tuesday, October 12, from 12:00 p.m. to 1:30 p.m. EDT, Mayo Clinic experts will discuss the latest information on the SARS-CoV-2 delta variant’s impact on vaccine recommendations for the general population and for solid-organ transplant recipients. Additional topics will include breakthrough infections in normal versus immunocompromised hosts and the most current vaccine updates.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Featured Expert: Gregory A. Poland, M.D., emeritus consultant, Division of General Internal Medicine; Mary Lowell Leary Emeritus Professor of Medicine; director, Mayo Vaccine Research Group
  • Featured Expert: Sadia Z. Shah, M.D., M.B.A., consultant, Division of Pulmonary Medicine; interim medical director, Lung Transplant Program, Mayo Clinic in Arizona; assistant professor of medicine

Learning Objectives

Upon completion of this activity, you will be able to:

  • Describe the current global epidemiology of SARS CoV-2 variants
  • Define breakthrough infections including immunosuppressed populations
  • Discuss the best strategies for managing immunocompromised groups if not responsive to vaccines
  • Discuss the importance of 3rd vaccine dose given to the immunocompromised and over 65 age groups

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Commercial Support

This educational activity is supported in part by an
independent medical education grant from

Pfizer, Inc.

and is in accordance with ACCME guidelines.